About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Predicting Chemo Toxicity Using Geriatric Forms | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT07163169

Predicting Chemo Toxicity Using Geriatric Forms

This prospective observational study aims to evaluate and compare the effectiveness of three geriatric assessment tools-CARG (Cancer and Aging Research Group score), G8 screening tool, and Frailty Sca...

Lead sponsor: Çanakkale Onsekiz Mart University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Çanakkale Onsekiz Mart University

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients aged 65 years or older.
•Histologically confirmed cancer diagnosis with a pre-planned chemotherapy regimen (adjuvant, neoadjuvant, or palliative intent).
•Chemotherapy not yet initiated at the time of enrollment.
•Clinically stable condition, as assessed by the oncologist.
•Willingness and ability to provide written informed consent.

Exclusion Criteria

•Presence of acute infection or advanced organ failure (cardiac, hepatic, or renal).
•Severe psychiatric illness or cognitive impairment that interferes with the ability to complete assessments.
•Patients receiving concurrent hormonal therapy, targeted therapy, immunotherapy, or radiotherapy.
•Diagnosis of hematologic malignancies (e.g., leukemia, lymphoma, myeloma).

Related studies

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NCT05545306 · Obesity, Normal Physiology, and more

A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

NCT06815120 · Catheter Blockage, Oncology, and more

Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging

NCT03581318 · Normal and Abnormal Cardiovascular Physiology

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

NCT06237816 · Cancer, Oncology

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 9, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment150

Start dateDec 2024

Last updatedSep 9, 2025

Condition

Oncology Geriatric Oncology Physiology

Locations shown

Çanakkale Onsekiz Mart Univercity

Çanakkale

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 9, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions